Back
Insmed 10K Form
Sell
50
INSM
Insmed
Last Price:
$70.51
Seasonality Move:
7.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | INSM/Insmed Quarterly |
| 2023-10-26 | 10Q | INSM/Insmed Quarterly |
| 2023-08-03 | 10Q | INSM/Insmed Quarterly |
| 2023-05-04 | 10Q | INSM/Insmed Quarterly |
| 2022-10-27 | 10Q | INSM/Insmed Quarterly |
| 2022-08-04 | 10Q | INSM/Insmed Quarterly |
Receive INSM News And Ratings
See the #1 stock for the next 7 days that we like better than INSM
INSM Financial Statistics
Sales & Book Value
| Annual Sales: | $305.2M |
|---|---|
| Cash Flow: | $-184.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.70 |
| Price / Book: | 26.07 |
Profitability
| EPS (TTM): | -5.55000 |
|---|---|
| Net Income (TTM): | $-864.3M |
| Gross Margin: | $239.6M |
| Return on Equity: | 0% |
| Return on Assets: | -56.29% |
Insmed Earnings Forecast
Key Insmed Financial Ratios
-
The Gross Profit Margin over the past 25 years for INSM is 78.52%.
-
The Selling, General & Administrative Expenses for INSM have been equal to 112.87% of Gross Profit Margin.
-
The Research & Development expenses have been 187.09% of Revenue.
-
The Interest Expense is -10.17% of Operating Income.
-
The Net Earning history of INSM is -245.59% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 9 years.
Insmed Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INSM |
| CUSIP: | 457669 |
| Website: | insmed.com |
Debt
| Debt-to-Equity Ratio: | 1.98 |
|---|---|
| Current Ratio: | 6.37 |
| Quick Ratio: | 5.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |